(1.22%) 5 125.90 points
(1.15%) 38 666 points
(1.96%) 16 152 points
(-0.71%) $78.39
(5.21%) $2.14
(-0.11%) $2 307.00
(-0.54%) $26.68
(0.31%) $965.55
(-0.32%) $0.929
(-1.11%) $10.87
(-0.08%) $0.797
(0.41%) $91.50
Quarter results today
(bmo 2024-05-03)
Expected move: +/- 2.44%
Live Chart Being Loaded With Signals
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies...
Stats | |
---|---|
Dagens volum | 26 918.00 |
Gjennomsnittsvolum | 60 636.00 |
Markedsverdi | 241.06M |
EPS | £0 ( 2024-04-30 ) |
Last Dividend | £14.20 ( 2023-07-27 ) |
Next Dividend | £0 ( N/A ) |
P/E | 37.61 |
ATR14 | £3.22 (0.50%) |
Volum Korrelasjon
International Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
International Korrelasjon - Valuta/Råvare
International Økonomi
Annual | 2023 |
Omsetning: | £8.49M |
Bruttogevinst: | £8.49M (100.00 %) |
EPS: | £0.170 |
FY | 2023 |
Omsetning: | £8.49M |
Bruttogevinst: | £8.49M (100.00 %) |
EPS: | £0.170 |
FY | 2022 |
Omsetning: | £-21.10M |
Bruttogevinst: | £-21.10M (100.00 %) |
EPS: | £-0.550 |
FY | 2021 |
Omsetning: | £29.12M |
Bruttogevinst: | £0.00 (0.00 %) |
EPS: | £0.725 |
Financial Reports:
No articles found.
International Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£15.70 (N/A) |
£14.00 (N/A) |
£0 (N/A) |
£0 (N/A) |
£14.20 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £1.000 | 1995-11-13 |
Last Dividend | £14.20 | 2023-07-27 |
Next Dividend | £0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 15 | -- |
Total Paid Out | £191.80 | -- |
Avg. Dividend % Per Year | 2.11% | -- |
Score | 4.55 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.50 | |
Div. Directional Score | 8.52 | -- |
Year | Amount | Yield |
---|---|---|
1995 | £0 | 0.00% |
1996 | £0 | 0.00% |
1997 | £0 | 0.00% |
1998 | £0 | 0.00% |
1999 | £0 | 0.00% |
2000 | £0 | 0.00% |
2001 | £0 | 0.00% |
2002 | £0 | 0.00% |
2003 | £0 | 0.00% |
2004 | £0 | 0.00% |
2005 | £0 | 0.00% |
2006 | £0 | 0.00% |
2007 | £0 | 0.00% |
2008 | £0 | 0.00% |
2009 | £0 | 0.00% |
2010 | £0 | 0.00% |
2011 | £0 | 0.00% |
2012 | £0 | 0.00% |
2013 | £0 | 0.00% |
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £41.00 | 7.36% |
2019 | £26.40 | 4.63% |
2020 | £26.60 | 4.28% |
2021 | £29.90 | 3.70% |
2022 | £29.70 | 4.04% |
2023 | £14.20 | 1.97% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SUPR.L | Dividend Knight | 2023-07-13 | Quarterly | 8 | 3.25% | |
KEYS.L | Dividend Knight | 2023-09-21 | Annually | 7 | 2.29% | |
CCJI.L | Dividend Knight | 2023-07-06 | Semi-Annually | 9 | 2.14% | |
QXT.L | Ex Dividend Junior | 2023-07-27 | Sporadic | 11 | 0.46% | |
GHH.L | Dividend Knight | 2023-06-22 | Annually | 27 | 0.91% | |
AMC.L | Dividend Knight | 2023-06-01 | Insufficient data to determine frequency | 2 | 55.57% | |
TPFG.L | Dividend Knight | 2023-09-21 | Annually | 11 | 3.16% | |
MACF.L | Dividend King | 2023-09-14 | Semi-Annually | 32 | 1.94% | |
CREI.L | Dividend Knight | 2023-07-20 | Quarterly | 11 | 3.34% | |
RUR.L | Dividend Knight | 2023-06-22 | Sporadic | 20 | 10.67% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.651 | 1.500 | 10.00 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0223 | 1.200 | 9.26 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0241 | 1.500 | -0.844 | -1.265 | [0.1 - 1] |
payoutRatioTTM | 1.674 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 19.01 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 19.01 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0.213 | -1.500 | 6.45 | -9.67 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.676 | 2.00 | 9.77 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.676 | 2.00 | 9.66 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.240 | -1.500 | 9.04 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 1.000 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.629 | 1.000 | 10.00 | 10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.420 | 1.000 | 8.78 | 8.78 | [0.2 - 2] |
assetTurnoverTTM | 0.0343 | 0.800 | -3.10 | -2.48 | [0.5 - 2] |
Total Score | 10.54 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 37.45 | 1.000 | 6.32 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0241 | 2.50 | -0.542 | -1.265 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.676 | 2.00 | 9.77 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.45 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.676 | 2.00 | 9.77 | 10.00 | [0 - 30] |
payoutRatioTTM | 1.674 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 28.61 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 2.61 | 1.000 | 10.00 | 0 | [0.1 - 0.5] |
Total Score | 6.50 |
International
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of these companies to strategic buyers including major pharmaceutical companies or, in some cases, and through a flotation.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.